Company: PCRX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001104659-25-041219
Chunk: 70

Company: Pacira BioSciences, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 70
---
 | ​ | ​ | ​ | ​ |     601,875 | ​ | ​ | ​ | ​ | ​ |                                                       ― | ​ |      ​ | ​ | ​ | ​ | ―                                                             | ​ |       ​ | ​ | ​ | ​ | ―                                         | ​ |     ​ | ​ | ​ | ​ |                                                   ― | ​ |         ​ |   |   |

(1) Amounts represent the threshold, target, and maximum amount that could have been earned under the cash LTIP in 2024. For information relating to amounts actually earned under the cash LTIP in 2024, see page 68 as well as the column in the summary compensation table titled “non-equity incentive plan compensation” on Page 77. Payments of the amounts earned are subject to an additional three-year vesting period commencing after the performance year. (2) Amounts reflect the aggregate grant date fair value of grants computed in accordance with stock-based accounting rules (FASB ASC Topic 718, Stock Compensation ). Assumptions used in the calculations of these amounts are included in Note 13 to our consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2024. The option grants referenced above vest as to as to 25% of the option shares on the first anniversary of the grant date, and vest as to the remaining shares in successive equal quarterly installments over the subsequent three years. The RSU grants referenced above vest as to 25% of the RSU shares in four equal annual installments. All vesting is subject to the requirement that the named executive officer remains in continuous service with the Company at the vesting date. (3) Mr. Stack announced his retirement in September 2023 and served as Chief Executive Officer and Chairman until January 1, 2024. As a result, Mr. Stack was not granted any equity awards in 2024. (4) Represents RSU grants to each of Ms. Williams and Mr. Gaugler as a retention grant of 33,700 RSUs made in February 2024 that have a two-year cliff-vest occurring on February 1, 2026. For more information, see “Compensation in Connection with Leadership Transitions” on page 71.

78 | investor.pacira.com

TABLE OF CONTENTS Executive Compensation

OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END TABLE The following table sets forth certain information with respect to outstanding options